Streamlines review pathway for similar devices
Silver Spring, Maryland—(ENEWSPF)—March 29, 2018
Contact: Tara Rabin
The U.S. Food and Drug Administration today permitted marketing of the Dexcom G6 integrated continuous glucose monitoring (iCGM) system for determining blood glucose (sugar) levels in children aged two and older and adults with diabetes. This is the first type of continuous glucose monitoring system permitted by the agency to be used as…
